Survey: Pharmaceutical Scientists' Salaries Rose In 1990

Buoyed by strong demand for personnel to conduct research and development programs in the quest for new products, average annual salaries for pharmaceutical scientists rose significantly in 1990, a recently released survey found. However, according to the study, the recession dampened starting pay during the same year. Healthy gains were posted by professionals in government, industry, and academia, according to the American Association of Pharmaceutical Scientists (AAPS), which sponsored the

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Healthy gains were posted by professionals in government, industry, and academia, according to the American Association of Pharmaceutical Scientists (AAPS), which sponsored the survey.

The average annual salary for pharmaceutical scientists in industry was $66,300, a 4.9 percent increase over the 1989 level, while pay for these scientists rose by 7.3 percent in academia, to an average of $63,100. Government employees received $57,300 on average, a 5.3 percent gain, the results showed.

By contrast, average starting pay dropped 2.5 percent, to $43,400. And average salaries for new hires in industry remained flat, at $45,100.

The survey tallied responses from 1,705 pharmaceutical scientists who in early 1991 were asked to describe their status as of December 1990. All respondents belonged to AAPS, which has a total of 6,104 members and is based in Alexandria, Va.

By far, the majority of survey respondents were employed in industry--78 percent--and most were working in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Edward Silverman

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo